|
Bruker Corporation (BRKR) DCF Valuation
US | Healthcare | Medical - Devices | NASDAQ
|
- ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
- ✓ Professional Design: Trusted, Industry-Standard Templates
- ✓ Pre-Built For Quick And Efficient Use
- ✓ No Expertise Is Needed; Easy To Follow
Bruker Corporation (BRKR) Bundle
Streamline your analysis and improve precision with our Bruker Corporation (BRKR) DCF Calculator! Utilizing real data from Bruker and customizable assumptions, this tool empowers you to forecast, evaluate, and value Bruker Corporation like a seasoned investor.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2,072.6 | 1,987.5 | 2,417.9 | 2,530.7 | 2,964.5 | 3,256.2 | 3,576.6 | 3,928.5 | 4,315.0 | 4,739.5 |
| Revenue Growth, % | 0 | -4.11 | 21.66 | 4.67 | 17.14 | 9.84 | 9.84 | 9.84 | 9.84 | 9.84 |
| EBITDA | 380.0 | 320.7 | 497.1 | 545.3 | 599.0 | 630.3 | 692.3 | 760.4 | 835.2 | 917.4 |
| EBITDA, % | 18.33 | 16.14 | 20.56 | 21.55 | 20.21 | 19.36 | 19.36 | 19.36 | 19.36 | 19.36 |
| Depreciation | 75.6 | 80.5 | 89.2 | 88.8 | 114.9 | 122.2 | 134.3 | 147.5 | 162.0 | 177.9 |
| Depreciation, % | 3.65 | 4.05 | 3.69 | 3.51 | 3.88 | 3.75 | 3.75 | 3.75 | 3.75 | 3.75 |
| EBIT | 304.4 | 240.2 | 407.9 | 456.5 | 484.1 | 508.0 | 558.0 | 612.9 | 673.2 | 739.5 |
| EBIT, % | 14.69 | 12.09 | 16.87 | 18.04 | 16.33 | 15.6 | 15.6 | 15.6 | 15.6 | 15.6 |
| Total Cash | 684.9 | 731.8 | 1,168.2 | 645.5 | 488.3 | 1,043.0 | 1,145.6 | 1,258.4 | 1,382.2 | 1,518.2 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 362.2 | 335.3 | 416.9 | 595.3 | 621.8 | 625.7 | 687.3 | 754.9 | 829.2 | 910.8 |
| Account Receivables, % | 17.48 | 16.87 | 17.24 | 23.52 | 20.97 | 19.22 | 19.22 | 19.22 | 19.22 | 19.22 |
| Inventories | 577.2 | 692.3 | 710.1 | 803.7 | 968.3 | 1,019.0 | 1,119.3 | 1,229.4 | 1,350.3 | 1,483.2 |
| Inventories, % | 27.85 | 34.83 | 29.37 | 31.76 | 32.66 | 31.29 | 31.29 | 31.29 | 31.29 | 31.29 |
| Accounts Payable | 118.4 | 134.6 | 147.4 | 178.4 | 202.7 | 211.4 | 232.2 | 255.1 | 280.2 | 307.8 |
| Accounts Payable, % | 5.71 | 6.77 | 6.1 | 7.05 | 6.84 | 6.49 | 6.49 | 6.49 | 6.49 | 6.49 |
| Capital Expenditure | -73.0 | -98.2 | -92.0 | -119.0 | -106.9 | -134.0 | -147.2 | -161.7 | -177.6 | -195.0 |
| Capital Expenditure, % | -3.52 | -4.94 | -3.8 | -4.7 | -3.61 | -4.12 | -4.12 | -4.12 | -4.12 | -4.12 |
| Tax Rate, % | 21.5 | 21.5 | 21.5 | 21.5 | 21.5 | 21.5 | 21.5 | 21.5 | 21.5 | 21.5 |
| EBITAT | 214.1 | 167.9 | 287.2 | 327.1 | 380.0 | 366.6 | 402.6 | 442.3 | 485.8 | 533.6 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -604.3 | 78.2 | 197.8 | 55.9 | 221.2 | 308.9 | 248.7 | 273.2 | 300.1 | 329.6 |
| WACC, % | 9.16 | 9.16 | 9.16 | 9.17 | 9.21 | 9.18 | 9.18 | 9.18 | 9.18 | 9.18 |
| PV UFCF | ||||||||||
| SUM PV UFCF | 1,125.2 | |||||||||
| Long Term Growth Rate, % | 4.00 | |||||||||
| Free cash flow (T + 1) | 343 | |||||||||
| Terminal Value | 6,622 | |||||||||
| Present Terminal Value | 4,270 | |||||||||
| Enterprise Value | 5,395 | |||||||||
| Net Debt | 891 | |||||||||
| Equity Value | 4,504 | |||||||||
| Diluted Shares Outstanding, MM | 147 | |||||||||
| Equity Value Per Share | 30.59 |
What You Will Get
- Real Bruker Data: Preloaded financials – from revenue to EBIT – based on actual and projected figures.
- Full Customization: Adjust all critical parameters (yellow cells) like WACC, growth %, and tax rates.
- Instant Valuation Updates: Automatic recalculations to analyze the impact of changes on Bruker’s fair value.
- Versatile Excel Template: Tailored for quick edits, scenario testing, and detailed projections.
- Time-Saving and Accurate: Skip building models from scratch while maintaining precision and flexibility.
Key Features
- Comprehensive Financial Data: Gain access to reliable pre-loaded historical figures and future forecasts for Bruker Corporation (BRKR).
- Flexible Forecast Parameters: Modify highlighted cells for key metrics such as WACC, growth rates, and profit margins.
- Real-Time Calculations: Receive instant updates to DCF, Net Present Value (NPV), and cash flow assessments.
- User-Friendly Dashboard: Intuitive charts and summaries to effectively showcase your valuation findings.
- Designed for All Skill Levels: A straightforward layout tailored for investors, CFOs, and consultants alike.
How It Works
- Download the Template: Gain immediate access to the Excel-based BRKR DCF Calculator.
- Input Your Assumptions: Modify the yellow-highlighted cells for growth rates, WACC, margins, and other variables.
- Instant Calculations: The model will automatically refresh Bruker Corporation’s intrinsic value.
- Test Scenarios: Experiment with various assumptions to see how they affect the valuation.
- Analyze and Decide: Leverage the results to inform your investment or financial strategy.
Why Choose This Calculator for Bruker Corporation (BRKR)?
- Accurate Data: Real Bruker financials provide trustworthy valuation outcomes.
- Customizable: Modify essential parameters such as growth rates, WACC, and tax rates to align with your forecasts.
- Time-Saving: Pre-built calculations save you from starting from the ground up.
- Professional-Grade Tool: Tailored for investors, analysts, and consultants in the field.
- User-Friendly: Easy-to-navigate layout and clear instructions make it accessible for all users.
Who Should Use This Product?
- Investors: Evaluate Bruker Corporation’s valuation before making stock transactions.
- CFOs and Financial Analysts: Enhance valuation methodologies and assess financial forecasts.
- Startup Founders: Understand the valuation metrics of established companies like Bruker Corporation.
- Consultants: Create detailed valuation reports for clients in the life sciences sector.
- Students and Educators: Utilize current market data to learn and teach valuation strategies.
What the Template Contains
- Operating and Balance Sheet Data: Pre-filled Bruker Corporation (BRKR) historical data and forecasts, including revenue, EBITDA, EBIT, and capital expenditures.
- WACC Calculation: A dedicated sheet for Weighted Average Cost of Capital (WACC), including parameters like Beta, risk-free rate, and share price.
- DCF Valuation (Unlevered and Levered): Editable Discounted Cash Flow models showing intrinsic value with detailed calculations.
- Financial Statements: Pre-loaded financial statements (annual and quarterly) to support analysis.
- Key Ratios: Includes profitability, leverage, and efficiency ratios for Bruker Corporation (BRKR).
- Dashboard and Charts: Visual summary of valuation outputs and assumptions to analyze results easily.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.